Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). These are not all the …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …
Treatments – National Organization for Tardive Dyskinesia
VMAT2 inhibitors: There are two FDA-approved drugs to treat tardive dyskinesia, Ingrezza (valbenazine) and Austedo (deutetrabenazine). These medications were approved in 2017 and are known as …
What Medications Cause Tardive Dyskinesia? - Verywell Health
Dec 8, 2025 · Tardive dyskinesia is a side effect that causes uncontrollable, repetitive body movements. It is caused by long-term use of antipsychotic medications.
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine for ...
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia …
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
List of 21 Tardive Dyskinesia Medications Compared - Drugs.com
Mar 5, 2024 · Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine (Ingrezza), tetrabenazine (Xenazine), amantadine, vitamin B6 (pyridoxine) and pyridoxal …
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
Nov 7, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.
The dose of deutetrabenazine (Austedo) is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. The package insert contains specific dosing …